Collections

Latest programs

• Current and Future Roles of Immunotherapy and Targeted Therapy in the Management of Advanced Gastroesophageal Cancers

• Investigators Provide Perspectives on the Best-Practice Use of Immunotherapy for Endometrial Cancer

+4 more programs

Latest programs

• Optimal Use of PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer

• New Datasets and Their Implications for Breast Cancer Management

Latest programs

• Optimizing Biomarker Assessment and Related Treatment Decision-Making for Patients with HR-Positive Metastatic Breast Cancer

• Key Presentations from the 2025 American Society of Hematology (ASH) Annual Meeting — Chronic Lymphocytic Leukemia

+24 more programs

Latest programs

• Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Oral SERDs for Breast Cancer

• Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia

+16 more programs

Latest programs

• Understanding and Caring for Patients with Nonmelanoma Skin Cancers

• What Is Molecular Residual Disease Analysis and Why Is It Clinically Relevant in Colorectal Cancer?

+6 more programs

Latest programs

• CELMoDs for Multiple Myeloma

• The Emerging Role of Cereblon E3 Ligase Modulators in Multiple Myeloma

+2 more programs